Summarized by Plex Health
Last Updated: 02 May 2022
treatment of dysphagia with pyridostigmine bromide in a patient with the pharyngeal-cervical-brachial variant of guillain-barré syndrome. "treatment of dysphagia with pyridostigmine bromide in a patient with the pharyngeal-cervical-brachial variant of guillain-barré syndrome.", by Lee KL, Lim OK, Lee JK, Park KD. F1: (A) Barium liquid did not transfer to the esophageal phase because of pharyngeal muscle weakness. The image showed severe retention of material at the vallecula (white arrow) and the pyriform sinus (triangle). (B) The...

Pyridostigmine impacts chemicals in the body that are included in the communication between nerve impulses and muscle mass movement. Pyridostigmine is used to treat the symptoms of myasthenia gravis. It is also used in military workers who have been subjected to nerve gas. Pyridostigmine may be used for purposes not listed in this medication guide. If you have a bladder or bowel blockage, you need to not use pyridostigmine. You must not use pyridostigmine if you are allergic to it, or if you have a bladder or bowel obstruction. FDA pregnancy group C. It is not known whether pyridostigmine will hurt a coming baby. If you are pregnant or plan to come to be pregnant while utilizing pyridostigmine, inform your physician. It is not understood whether pyridostigmine enters breast milk or if it could damage a nursing baby. If you are breast-feeding a child, tell your physician. Pyridostigmine is not accepted for use by any individual younger than 18 years old. Do not take this medication in bigger or smaller sized amounts or for longer than suggested. Take this medicine with food or milk if it distress your stomach. Measure fluid medication with the dosing syringe offered, or with a special dose-measuring spoon or medication mug. Carefully follow your medical professional's instructions about just how much medicine to take and when to take it. Your physician might periodically change your dosage to make certain you get the best results. You may need to quit making use of the medication for a brief time. Miss the missed dosage if it is nearly time for your following scheduled dose.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
4991C9H13N2O2+181.21C[N+]1=CC=CC(=C1)OC(=O)N(C)CC[N+]1=CC=CC(=C1)OC(=O)N(C)CInChI=1S/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1RVOLLAQWKVFTGE-UHFFFAOYSA-N(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate0.7181.097702662181.09770266233.418310221300000001
*** If you want us to remove all links leading to your domain from and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.